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INTRODUCTION
The influenza A virus (IAV) is one of the most
common infectious pathogens in human, causing
considerable morbidity and mortality in infants
and older persons (1). IAV readily infects and rep-
licates in the airway epithelial cells, though occa-
sionally replicates in the central nervous system,
particularly in children younger than 6 years of age.
There appears little doubt as to the encephalitis of
patients infected with a neurovirulent strain of IAV,
such as the 1918/1919 pandemic (2). There are
also rare, though often fatal, cases of encephalopathy
due to infection by non-neurovirulent IAV in Reye’s
syndrome children treated with antipyretics (3-7).
A systemic disorder of mitochondrial β-oxidation
and degeneration of the liver with fatty infiltration
are suspected to be involved in acute encephalitis
or encephalopathy of patients suffering from Reye’s
syndrome. However, the pathological roles of an
impaired mitochondrial β-oxidation in the influen-
za encephalitis and the mechanism of cerebral IAV
invasion remain unclear. This review focuses on
the pathogenesis of influenza-virus-associated en-
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cephalitis or encephalopathy, and discusses the
roles of inflammatory cytokines, inducible nitric
oxide synthase (iNOS) and mini-plasmin in the
development of encephalitis.
INFLUENZA A VIRUS AND ITS PATHOGENESIS
Influenza viruses are enveloped, negative-stranded RNA
viruses, which belong to the family of Orthomyxoviridae ,
and are subclassified into A, B and C, of which the
A viruses are the most important pathogens (8).
IAV-RNA is composed of eight segmented genes,
which encode for ten different proteins, including
envelope glycoproteins hemagglutinin (HA) and
neuraminidase (NA), matrix protein M1, nucleoprotein,
three polymerases (PB1, PB2 and PA), ion chan-
nel protein M2, and nonstructural proteins (NS1
and NS2). Anti-HA antibodies inhibit viral attach-
ment, and are classified (H1-H15) according to their
antigenicity. Anti-NA antibodies restrict the viral
replication and are distinguished as nine (N1-N9)
subtypes. Viruses with HA types, H1, H2 and H3,
and NA types, N1 and N2, have been identified in
human and H3N2 subtype of IAV is predominant
in Japan (4, 5, 9). During the years 1989-1999, H3N2
and H1N1subtypes of IAV and B type influenza vi-
ruses were co-circulating in Chinese populations
(Fig. 1), while IAV H3N2 was the predominant
strain (76%), associated with a morbidity as high
as 10% in the Beijing area (10).
Infection with IAV affects the upper respiratory
tract first, followed by an acute and diffuse inflam-
mation of the broncho-alveolar tract. Clinically, IAV
infections are accompanied by the production of
endogenous pyrogens, high fever, malaise and
pulmonary complications. The pathogenesis and
organ tropism of the virus are primarily determined
by genetic polymorphisms of its subtypes, and by
organ-specific trypsin-type processing protease(s)
for viral envelope glycoprotein HA, i.e. tryptase
Clara, ectopic anionic trypsin and mini-plasmin in
the airways, which induce the membrane fusion
activity of a virus in vivo and allow the viral genome
to enter the cells (11-14). In influenza encephalitis,
the heavy immunoreactive deposits of both virus
antigen and mini-plasmin, which amplify the multi-
plication of IAV and destructs the blood-brain bar-
rier (BBB) in vivo , have been exclusively detected
in the brain capillaries of newborn mice infected
by IAV. These changes, as well as cerebral edema,
were more prominent in newborn juvenile visceral
steatosis (JVS) mice, which have an inherited defect
of the sodium-dependent carnitine transporter,
Fig. 1. Prevalence of influenza virus in China in 1998.
Peaks of influenza virus prevalence occurred in the summer
and in the winter. IAV H3N2 and H1N1 subtypes and B type
viruses were co-circulating among the human population, and
the subtype H3N2 virus was the predominant strain (76%)
(10).
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OCTN2, in the plasma membrane, than in newborn
wild type (WT) mice. Large amounts of mini-plasmin
are generated from plasmin or plasminogen by
granulocyte elastase in pulmonary inflammatory
loci, along with an infiltration of granulocytes and
monocytes (14). Since there was little infiltration
of inflammatory cells in the brain capillaries even
after IAV infection, and mini-plasmin was not de-
tected in the capillaries before infection, accumu-
lated mini-plasmin in the brain capillaries might be
transferred from lungs with pneumonia. Mini-plasmin
accumulated in the brain capillaries may increase
the permeability of endothelial cells by its proteolytic
activity, as well as transform capillary endothelial
cells from non-susceptible to susceptible to the
multiplication of IAV (Yao et al ., manuscript sub-
mitted for publication). Studies of the molecular
mechanisms of mini-plasmin accumulation in the brain
capillaries of mice with an impaired mitochondrial
fatty acid metabolism are currently in progress.
INFLUENZA-ENCEPHALITIS AND REYE'S
SYNDROME
Reye’s syndrome is characterized by encephali-
tis and fatty degeneration of the liver due to an im-
paired free fatty acid metabolism and β-oxidation
in mitochondria in children treated with aspirin,
ibuprofen and diclofenac, and, in over 85% of cases,
infected with influenza or varicella (15, 16). To deter-
mine whether a disorder of mitochondrial β-oxidation
is a risk factor for influenza encephalopathy or en-
cephalitis, we infected newborn JVS mice and ac-
quired carnitine deficiency mice with non-neurotropic
IAV/Aichi/2/68 (H3N2), which has been classified
as a dominant and epidemic influenza subtype since
1968. Carnitine is an obligatory amino acid for the
transfer of long-chain fatty acids from the cytosol
to mitochondria. These fatty acids contribute the
major source of energy in the mitochondria, par-
ticularly in patients with high fever, vomiting and
anorexia during the newborn/suckling periods.
Antipyretics, such as aspirin, ibuprofen and diclofenac,
have potent anti-inflammatory effects, though impair
the mitochondrial fatty acid metabolism and genera-
tion of ATP. Furthermore, influenza virus proteins,
such as M protein, PB2 and PB1-F2, also cause
mitochondrial damage and inhibition of β-oxidation
(17, 18). Therefore influenza virus infection in com-
bination with antipyretic treatment may cause a sys-
temic disorder of fatty acid metabolism, particular-
ly in the newborn/suckling period (19). Newborn
JVS mice have significantly higher numbers of
virus-genome in the brains, accumulation of virus
antigen in the capillaries, and an increased blood-brain
barrier permeability after intranasal infection with
non-neurotropic IAV. Mini-plasmin was prominent-
ly accumulated with virus antigen in the brain cap-
illaries of JVS mice, but only mildly in WT mice. Although
the mechanisms of IAV-associated encephalopathy
by antipyretics have not been clarified, Funato et al .
have recently described a single-base mutation of
the CYP2C9 gene, the major cytochrome P450 gene
product that catalyzes diclofenac in human liver, in
one of thirty healthy subjects (20). This mutation in the
CYP2C9 gene may be related to diclofenac-induced
influenza-virus-associated encephalitis or encephalopathy.
AVIAN IAV INFECTION AND ENCEPHALI-
TIS
It is noteworthy that, during the influenza sur-
veillance of 1998-1999 in China, five strains of avi-
an IAVs were isolated from patients with influenza-like
illness (10). To examine the infectivity of avian in-
fluenza virus in mammalian species, 4 -week old ddY
mice were infected intranasally with the H5N1 A/
Hong Kong/156/97 (HK156) and A/Hong Kong/
483/97 (HK483) influenza viruses isolated from hu-
mans. HK156 and HK483 required 200 and 5 plaque
forming units of virus, respectively, to administer
a 50% lethal dose to the mice in a 10 µl volume of
inoculum. Both viruses caused encephalitis and se-
vere bronchopneumonia (21). While the severity
of lung lesions caused by the viruses was similar,
lesions in the brain caused by HK483 were more
extensive than those caused by HK 156. This was con-
cordant with the measurements of brain homogenates
virus titers, which were over 100-fold higher in
HK483- than in HK156-infected mice, while virus
titers in lung homogenates were nearly identical.
Both viruses were detected in heart, liver, spleen
and kidney homogenates, and in the blood of the
infected mice. Virus antigen was sporadically detect-
ed by immunohistochemical staining, though was
associated with no degenerative changes in the heart
and liver. The antigen was not detected in the thy-
mus, spleen, pancreas, kidney or gastrointestinal
tract. In contrast, it was found regularly in adipose
tissue attached to these organs. The adipose tissue
showed severe degenerative changes, and contain-
ed high virus titers, similar to those measured in
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lungs. Thus, infection with HK156 and HK483 in this
mouse model was pneumo-, neuro- and adipo-tropic,
not pantropic. Furthermore, the neurotropism of
HK483 was higher than that of HK156, which may
explain its higher lethality.
CYTOKINE LEVELS AFTER IAV INFEC-
TION
Analyses of the host immune responses are re-
quired to study the molecular pathologic mecha-
nisms of IAV. The infected epithelial cells and inflam-
matory leukocytes produce a variety of chemotactic,
proinflammatory, and other immunoregulatory
cytokines. The increase in expression of cytokine
genes is associated with the activation of NF-κB,
AP-1, STAT and IRF signal-transducing molecules
in the infected cells (22-26). We found a significant
increase in the expression of E-selectin, vascular
cellular adhesion molecule-1 (V-CAM-1), macrophage
inflammatory protein-2 (MIP-2), inducible nitric
oxide synthase (iNOS) and endothelin-1 (ET-1)
mRNAs, along with an increase in IAV-RNA in the
brain of WT mice after IAV infection, whereas these
mRNAs were undetectable in absence of infection
(Fig. 2). Among the mRNAs tested, the greatest
increases in the expressions of ET-1 and iNOS
mRNAs were detected in the brain. These proteins
have been reported to trigger the formation of edema
in various tissues.
TNF-α is a pro-inflammatory cytokine that causes
apoptotic tissue injury and a potent inhibitor of
mitochondrial respiration. It prominently induces
the mitochondrial permeability transition (MPT) in
living cells, resulting in a necrotic and apoptotic cell
death. Thus, an abrupt increase in TNF-α concen-
trations after virus infection in the systemic circu-
lation induces systemic MPT in multiple organs,
and MPT in cerebral capillary cells cause brain edema
in acute IAV encephalopathy or encephalitis (27).
We have found that the concentrations of TNF-α
in the brain of IAV-infected WT newborn mice
were significantly increased on day 5 after inocula-
tion, and that treatment with diclofenac further in-
creased these concentrations (Fig. 3). Since some
cytokines, such as IFN-α/β, IFN-r, and IL-2, are pro-
tective against influenza infection, whereas others,
such as IL-1, TNF-α and IL-6, are involved in the
progression of inflammation (26), further studies of
the concentrations of other cytokines in the brain,
and studies of their mutual interactions are required
to elucidate the pathogenesis of IAV encephalitis.
ROLE OF NITRIC OXIDE
Nitric oxide (NO) has complex and diverse func-
tions in physiologic and pathophysiologic process-
es in vivo. NO and oxygen radicals appear to be
key molecules explaining the pathogenesis of vari-
Fig. 2. Expression of IAV HA gene and mRNAs of ET-1,
iNOS, MIP-2, E-selectin, and V-CAM-1 in the brains of newborn
mice analyzed by RT-PCR.
IAV, influenza A virus ; iNOS, inducible nitric oxide synthase ;
ET-1, endothelin-1 ; E-selectin, endothelium selectin ; V-CAM-1,
vascular cellular adhesion molecular-1 ; MIP-2, macrophage in-
flammatory protein-2 ; GAPDH, glyceraldehyde-3-phosphate
dehydrogenase. Total RNA was extracted from the brains of
newborn WT mice on day 5 after inoculation. IAV replication
was measured directly by genome amplification, and the ex-
pressions of mRNAs of ET-1, iNOS, MIP-2, E-selectin, and
V-CAM-1 were analyzed by RT-PCR using random primers and
total RNA (1 µg/µl).
Fig. 3. Expression of TNF-α in the brain of newborn mice
after IAV infection.
The levels of TNF-α in the brains of IAV-infected newborn WT
mice were analyzed by enzyme-linked immunosorbent assay
(EIA) on days 3 and 5. A significant increase in TNF-α concen-
trations was measured on day 5 in IAV-infected mice (P <0.05).
Treatment with diclofenac further increased the concentrations
of TNF-α on days 3 (P <0.05) and 5 (P <0.01).
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ous infectious diseases, including influenza (28).
IAV infection promotes the release of reactive oxy-
gen (ROS) and nitrogen (RNS) species, such as
NO, into the extracellular space. ROS and RNS in-
duce tissue injury, and treatment with exogenous
antioxidants attenuates tissue damage and lowers
mortality in IAV-infected mice. NO, a product of iNOS,
is produced by activated macrophages, neutrophils,
type II pneumocytes, and airway epithelial cells
after virus infection (29). In the brain of newborn
WT mice, the concentrations of iNOS-mRNA in-
creased over time after virus inoculation (Fig. 4A),
and significant differences in these concentrations
(P <0.05) were measured on day 5 between the in-
fected and non-infected brains (Fig. 4B).
NO contributes to the antimicrobial host defense.
However, these oxygen and nitrogen reactive inter-
mediates cannot discriminate between exogenous
invading pathogens and the host itself and func-
tion as mediators of nonspecific innate defense
against various microbes. Reactive NO can affect
bacteria rather selectively, while the surrounding
normal tissue remains intact (Fig. 4C). In contrast,
in viral infections, free radical mediators cause
nonspecific oxidative injury as well as oxidative
stress to the virus-infected tissues.
Fig. 4. Increase in the expression of iNOS mRNA
(A) and NOS activities (B) in the brain of newborn
mice after IAV infection. Role of NO in virus and
bacterial infection (C).
(A) Expression of iNOS mRNA in the brain was
analyzed by RT-PCR on days 1, 3 and 5 after IAV
infection. Lines 1 & 2 correspond to day 1, lines 3
& 4 correspond to day 3, and line 5 & 6 correspond
to day 5 after IAV infection. No positive band is present
on day 1, and the expression of iNOS mRNA in-
creased over time after infection.
(B) Total NOS activity in the brain on day 5 after
IAV infection and in non-infected controls. A signifi-
cant difference in NOS activity (P <0.05) was observed
between the infected and non-infected animals (n=5
in each group).
(C) Schematic representation of the different bio-
logical effects of free radicals, such as O2- and NO,
and their product, ONCO-, in viral and bacterial in-
fections (28).
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ENDOTHELIN ISOPEPTIDES AS INFLAM-
MATORY MEDIATORS
The endothelins [ETs : ET-1, ET-2 and ET-3 (1-
21)], a family of 21-residue peptide were first iso-
lated from the culture medium of porcine endo-
thelial cells and shown to be vasoconstrictors (30).
Recent studies indicated that ETs are distributed
in various tissues and cells and serve a variety of
physiological and pathological functions, not only as
smooth-muscle constrictors, but also as inflammatory
mediators. Furthermore, the bioactive ET peptide fami-
ly has expanded. New, smooth-muscle-constricting,
31-amino acid endothelins [ETs(1-31)], have been
discovered by our group (31, 32). Attention has
been attracted to the new functions of these ET
isopeptides, such as chemokine function for eosinophils,
monocytes and neutrophils (33, 34), and mediators
of brain edema formation (35). In the brain, ETs
and their receptors localize in neurons, glial cells
and smooth muscle cells, and microvessel endo-
thelial cells play pathophysiologic roles by modu-
lating neuronal functions and cerebral blood flow.
We found that, after 5 days of IAV inoculation, the
concentrations of ET-1 (1-21) and ET-1 (1-31) in
the brain of WT newborn mice were significantly
higher than in non-infected brains. In the lungs,
changes in the concentrations of ET-1 (1-21) were
insignificant, whereas the concentrations of ET-1
(1-31) were significantly increased. Treatment with
diclofenac had no effect on cerebral ET-1 concen-
trations. Putting these observations together, an in-
crease in mRNA concentrations of ET-1 (Fig. 2)
and in cerebral protein concentrations of ET-1 (1-
21) and ET-1 (1-31) (Fig. 5) cause the formation of
edema in the brain after IAV infection.
CONCLUSIONS
The pathological mechanisms of influenza en-
cephalitis associated with an increase in the ex-
pressions of inflammatory mediators and accumu-
lation of mini-plasmin in the brain capillaries have
been presented in the light of current information.
The proinflammatory cytokine TNF-α and IAV pro-
teins cause mitochondrial injury, which, in turn,
may stimulate the gene expression of adhesion mol-
ecules, such as V-CAM-1 and E-selectin, in the brain
capillaries, causing the accumulation of mini-plasmin
on the surface of cerebral capillaries. Mini-plasmin
is a processing enzyme of HA of IAV, which induces
the viral envelope fusion activity and allows the
viral genome to enter the cells. This accumulation
may potentiate the multiplication of IAV in the brain
capillaries. In addition, increases in the mRNA ex-
pressions of iNOS and ET-1, which cause brain injury
and an increase in the BBB permeability, lead to se-
vere brain edema in IAV encephalitis or encephalopathy.
A greater understanding of the changes in the ex-
pression of inflammatory cytokines and of the mo-
lecular mechanism of mini-plasmin accumulation
Fig. 5. ET-1(1-21) and ET-1(1-31)
concentrations in the lungs and brains
of newborn mice infected with IAV
for 5 days.
Concentrations of ET-1(1-21) and ET-1
(1-31) were analyzed by EIA. Signifi-
cant increases in ET-1(1-31) in the
lungs and in ET-1(1-21) and ET-1(1-
31) in the brains (P <0.05) were observed
after IAV infection. Diclofenac (D) treat-
ment had not effect on brain concen-
trations of ET-1(1-21) and ET-1(1-31).
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in cerebral capillaries will provide profound insights
into several components of influenza encephalitis.
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